{"brief_title": "A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common", "brief_summary": "To compare the efficacy of fluconazole versus placebo in preventing the development of active coccidioidomycosis and other systemic fungal infections among HIV-infected patients with CD4 lymphocyte counts < 250 cells/mm3 who are living in the coccidioidal endemic area.", "detailed_description": "Patients are randomized to receive either fluconazole or placebo daily.", "condition": ["Mycoses", "HIV Infections", "Coccidioidomycosis"], "intervention_type": ["Drug"], "intervention_name": ["Fluconazole"], "criteria": "Inclusion Criteria Patients must have: - Documented HIV infection. - CD4 count < 250 cells/mm3. - No active coccidioidomycosis or other fungal disease requiring systemic antifungal therapy. - Residence in area considered to be endemic for Coccidioides immitis. - Consent of parent or guardian if under legal age of consent. Exclusion Criteria Co-existing Condition: Patients with the following symptoms or conditions are excluded: - Unable to take oral medication. - Positive serum cryptococcal antigen. Concurrent Medication: Excluded: - Systemic antifungal therapy. Patients with the following prior conditions are excluded: History of hypersensitivity to azole or imidazole compounds. Prior Medication: Excluded: - Systemic antifungal agents within 2 weeks prior to study entry.", "gender": "All", "minimum_age": "13 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "Coccidioidomycosis", "mesh_term": ["Infection", "Communicable Diseases", "HIV Infections", "Mycoses", "Coccidioidomycosis", "Coccidiosis", "Fluconazole"], "id": "NCT00002325"}